These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28730615)

  • 1. Vulvar cancer in high-income countries: Increasing burden of disease.
    Kang YJ; Smith M; Barlow E; Coffey K; Hacker N; Canfell K
    Int J Cancer; 2017 Dec; 141(11):2174-2186. PubMed ID: 28730615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing Trends in Vulvar Cancer Incidence and Mortality Rates in Australia Since 1982.
    Barlow EL; Kang YJ; Hacker NF; Canfell K
    Int J Gynecol Cancer; 2015 Nov; 25(9):1683-9. PubMed ID: 26495761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anal cancer in high-income countries: Increasing burden of disease.
    Kang YJ; Smith M; Canfell K
    PLoS One; 2018; 13(10):e0205105. PubMed ID: 30339668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geographic and temporal variations in the incidence of vulvar and vaginal cancers.
    Bray F; Laversanne M; Weiderpass E; Arbyn M
    Int J Cancer; 2020 Nov; 147(10):2764-2771. PubMed ID: 32410226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of vulvar high-grade precancerous lesions and cancer in Denmark before and after introduction of HPV vaccination.
    Rasmussen CL; Thomsen LT; Aalborg GL; Kjaer SK
    Gynecol Oncol; 2020 Jun; 157(3):664-670. PubMed ID: 32276790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in incidence and survival of women with invasive vulvar cancer in the United States and Canada: a population-based study.
    Akhtar-Danesh N; Elit L; Lytwyn A
    Gynecol Oncol; 2014 Aug; 134(2):314-8. PubMed ID: 24875124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New aspects of vulvar cancer: changes in localization and age of onset.
    Hampl M; Deckers-Figiel S; Hampl JA; Rein D; Bender HG
    Gynecol Oncol; 2008 Jun; 109(3):340-5. PubMed ID: 18407339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of a two- versus three-yearly cervical screening interval recommendation on cervical cancer incidence and mortality: an analysis of trends in Australia, New Zealand, and England.
    Simonella L; Canfell K
    Cancer Causes Control; 2013 Sep; 24(9):1727-36. PubMed ID: 23832659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vulvar cancer in Germany: increase in incidence and change in tumour biological characteristics from 1974 to 2013.
    Holleczek B; Sehouli J; Barinoff J
    Acta Oncol; 2018 Mar; 57(3):324-330. PubMed ID: 28799431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in incidence and survival of Dutch women with vulvar squamous cell carcinoma.
    Schuurman MS; van den Einden LC; Massuger LF; Kiemeney LA; van der Aa MA; de Hullu JA
    Eur J Cancer; 2013 Dec; 49(18):3872-80. PubMed ID: 24011936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vulval cancer incidence, mortality and survival in England: age-related trends.
    Lai J; Elleray R; Nordin A; Hirschowitz L; Rous B; Gildea C; Poole J
    BJOG; 2014 May; 121(6):728-38; discussion 739. PubMed ID: 24148762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update of HPV-associated female genital cancers in the United States, 1999-2004.
    Watson M; Saraiya M; Wu X
    J Womens Health (Larchmt); 2009 Nov; 18(11):1731-8. PubMed ID: 19951205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global burden of human papillomavirus and related diseases.
    Forman D; de Martel C; Lacey CJ; Soerjomataram I; Lortet-Tieulent J; Bruni L; Vignat J; Ferlay J; Bray F; Plummer M; Franceschi S
    Vaccine; 2012 Nov; 30 Suppl 5():F12-23. PubMed ID: 23199955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global incidence, risk factors and trends of vulvar cancer: A country-based analysis of cancer registries.
    Huang J; Chan SC; Fung YC; Pang WS; Mak FY; Lok V; Zhang L; Lin X; Lucero-Prisno DE; Xu W; Zheng ZJ; Elcarte E; Withers M; Wong MCS;
    Int J Cancer; 2023 Nov; 153(10):1734-1745. PubMed ID: 37531169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of vulvar cancer in Croatia.
    Barišić I; Čukelj P; Brkić Biloš I; Šekerija M
    Croat Med J; 2023 Apr; 64(2):103-109. PubMed ID: 37131312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating a cluster of vulvar cancers in young women: distribution of human papillomavirus and HPV-16 variants in vulvar dysplastic or neoplastic biopsies.
    Tan SE; Garland SM; Rumbold AR; Zardawi I; Taylor-Thomson D; Condon JR; Tabrizi SN
    Sex Health; 2013 Mar; 10(1):18-25. PubMed ID: 23158206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors.
    Vaccarella S; Lortet-Tieulent J; Plummer M; Franceschi S; Bray F
    Eur J Cancer; 2013 Oct; 49(15):3262-73. PubMed ID: 23751569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-based incidence rates of malignant melanoma of the vulva in Germany.
    Stang A; Streller B; Eisinger B; Jöckel KH
    Gynecol Oncol; 2005 Jan; 96(1):216-21. PubMed ID: 15589604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in incidence and long-term survival of Japanese women with vulvar cancer: a population-based analysis.
    Tanaka Y; Ueda Y; Kakuda M; Yagi A; Okazawa A; Egawa-Takata T; Matsuzaki S; Kobayashi E; Yoshino K; Fukui K; Ito Y; Nakayama T; Kimura T
    Int J Clin Oncol; 2019 Sep; 24(9):1137-1142. PubMed ID: 31025128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vulvar carcinoma in Norway: A 50-year perspective on trends in incidence, treatment and survival.
    Meltzer-Gunnes CJ; Småstuen MC; Kristensen GB; Tropé CG; Lie AK; Vistad I
    Gynecol Oncol; 2017 Jun; 145(3):543-548. PubMed ID: 28356187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.